Back to EUR-Lex homepage

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search
You are here

Document 62009CN0156

Case C-156/09: Reference for a preliminary ruling from the Bundesfinanzhof (Germany) lodged on 6 May 2009 — Finanzamt Leverkusen v Verigen Transplantation Service International AG

OJ C 180, 1.8.2009, p. 25–25 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

1.8.2009   

EN

Official Journal of the European Union

C 180/25

Reference for a preliminary ruling from the Bundesfinanzhof (Germany) lodged on 6 May 2009 — Finanzamt Leverkusen v Verigen Transplantation Service International AG

(Case C-156/09)

2009/C 180/43

Language of the case: German

Referring court

Bundesfinanzhof

Parties to the main proceedings

Appellant: Finanzamt Leverkusen

Respondent: Verigen Transplantation Service International AG

Questions referred

1.

Is the first paragraph of Article 28bF of Sixth Council Directive 77/388/EEC of 17 May 1977 (1) on the harmonisation of the laws of the Member States relating to turnover taxes to be interpreted as meaning that:

(a)

cartilage material (‘biopsy material’) which is taken from a human being and entrusted to an undertaking for the purpose of cell multiplication and subsequent return as an implant for the patient concerned constitutes ‘movable tangible property’ for the purposes of this provision,

(b)

the removal of joint cartilage cells from the cartilage material and the subsequent cell multiplication constitute ‘work’ on movable tangible property for the purposes of this provision,

(c)

the service has been supplied to a customer ‘identified for valued added tax purposes’ simply if the value added tax identification number is stated in the invoice of the supplier of the service, without any express written agreement as to its use having been made?

2.

If any of the above questions is answered in the negative:

Is Article 13A(1)(c) of Sixth Council Directive 77/388/EEC of 17 May 1977 on the harmonisation of the laws of the Member States relating to turnover taxes to be interpreted as meaning that the removal of the joint cartilage cells from the cartilage material taken from a human being and the subsequent cell multiplication constitute the ‘provision of medical care’ where the cells obtained from the cell multiplication are reimplanted in the donor?

(1)  OJ 1977 L 145, p. 1.

Top